Full Press Release Details
CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced that management will participate in the following upcoming virtual investor conferences:
RBC Capital Markets Global Healthcare Conference
Presentation on Wednesday, May 19, 2021 at 2:30 p.m. ET
Oppenheimer Rare & Orphan Disease Summit
Prerecorded presentation available on Friday, May 21, 2021 at 8:00 a.m. ET
The events will be available via webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. Replays of the webcasts will be available for 90 days following the events.
Tags
praxis precision medicines